These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10151735)

  • 1. Increased adverse drug reaction reporting through wall-mounted ADR reporting cards.
    Szymusiak-Mutnick BA; Ross MB
    Formulary; 1995 Aug; 30(8):471-3. PubMed ID: 10151735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting a commercially available software program to improve ADR reporting.
    Ries AJ; Kraynak MA
    Formulary; 1995 Nov; 30(11):697-8, 703-4. PubMed ID: 10152873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.
    Schumock GT; Thornton JP; Witte KW
    Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventability and severity assessment in reporting adverse drug reactions.
    Hartwig SC; Siegel J; Schneider PJ
    Am J Hosp Pharm; 1992 Sep; 49(9):2229-32. PubMed ID: 1524068
    [No Abstract]   [Full Text] [Related]  

  • 13. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
    Jimmy B; Jose J; Rao PG
    Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a comprehensive medication reaction reporting system.
    Yee WP; Norton LL; Catania HF
    Hosp Pharm; 1995 May; 30(5):384-5, 389-91, 394-6. PubMed ID: 10142377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control charts to monitor rates of adverse drug reactions.
    Schumock GT; Seeger JD; Kong SX
    Hosp Pharm; 1995 Dec; 30(12):1088, 1091-2, 1095-6. PubMed ID: 10153656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria-based adverse drug reaction reporting and the use of a relational database.
    Hatton RC
    Top Hosp Pharm Manage; 1992 Jul; 12(2):40-8. PubMed ID: 10128728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.